Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Dual-brain-targeting prodrug commonly modified by glucose and vitamin C

A vitamin and glucose technology, applied in the field of medicine

Inactive Publication Date: 2018-04-13
SICHUAN UNIV
View PDF3 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Studies have shown that these specific transporters have high selectivity, and usually specific carrier proteins can only transport specific substrates

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Dual-brain-targeting prodrug commonly modified by glucose and vitamin C
  • Dual-brain-targeting prodrug commonly modified by glucose and vitamin C
  • Dual-brain-targeting prodrug commonly modified by glucose and vitamin C

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] Preparation of Compound 2

[0024]

[0025] NaH (24.0 g, 0.60 mol) was added to anhydrous DMF (300 ml) to form a suspension, and a solution of compound glucose 1 (15.0 g, 0.083 mol) in anhydrous DMF was added. After stirring for 30 min, BnBr (90 ml, 0.96 mol) was added dropwise under ice cooling, and after 10 min, it was stirred at room temperature for 24 h. Add 50 ml of methanol slowly, distill off DMF under reduced pressure, and use CH 2 Cl 2 (300 ml) to dissolve the residue, wash with saturated brine, and wash the organic layer with anhydrous Na 2 SO 4 Dry, filter, and concentrate the filtrate to a yellow oil. Purified by column chromatography to obtain 46.1 g of white solid compound with a yield of 77.8%. Mp: 88-90°C. 1 H NMR (400MHz, CDCl 3 ) δ: 3.47-3.57 (m, 2H), 3.65 (t, 2H, J = 7.2 Hz), 3.74 (d, 1H, J =4.8 Hz), 3.77-3.80 (m, 1H), 4.52-5.02 (m, 11H), 7.13-7.41 (m, 25H).

Embodiment 2

[0027] Preparation of compound 3

[0028]

[0029] to molten ZnCl 2 (6.71 g, 49.30 mmol) was added AcOH-Ac 2 O (1:5, 75 ml), cooled to 0°C, added dropwise in Ac 2 Compound 2 (5.94 g, 9.42 mmol) in O (37 ml). Stir at room temperature for 1.5 h, add 200 ml of ice water, filter, and then dilute with CH 3 After OH recrystallization, 4.30 g of white solid was obtained, with a yield of 78.3%. Mp: 113-115°C. 1 H NMR (400 MHz, CDCl 3) δ: 2.05 (s, 3H), 3.48-3.58 (m, 3H), 3.66 (t, 1H, J = 8.8 Hz), 4.22-4.97 (m, 11H), 7.24-7.38 (m, 20H).

Embodiment 3

[0031] Preparation of Compound 4

[0032]

[0033] to CH 3 CH in ONa (0.47 g, 8.13 mmol) 3 Add compound 3 (8.50 g, 14.59 mmol) to OH (100 ml) solution, stir at room temperature for 5 h, add 200 ml of ice water and stir for 30 min, filter, and successively wash with saturated NaHCO 3 Wash with water and dry under vacuum to obtain 7.80 g of white solid with a yield of 98.9%. Mp: 104-106°C.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a dual-brain-targeting prodrug commonly modified by glucose and vitamin C; the dual-brain-targeting prodrug is the structure shown in a general formula (I) or pharmaceuticallyacceptable salts and aquo-complex; the formula is as shown in the specification. In which, X represents -(CH2)a , C(O) (CH2)a C(O) or (CH2)b O , (CH2)b NH , C(O) (CH2)b O , C(O) (CH2)b NH ; a represents 0-6, b represents 1-4; Y represents (CH2)n , C(O) (CH2)n C(O) or C(O) (CH2)m , (CH2)m C(O) ; n represents 0-6, m represents 1-4; Drug represents a drug applied to a central nerve system.A series of prodrug can improve the brain targeting property and pivot concentration, so as to enhance the drug effect; meanwhile, the drug distribution at a peripheral organ is reduced, and the toxic and side effects of the drug are reduced.

Description

technical field [0001] The invention relates to a class of novel compounds, in particular to the design, preparation, targeting and efficacy evaluation of a class of dual brain-targeted prodrugs based on glucose and vitamin C. It belongs to the field of medical technology. Background technique [0002] According to statistics, about 1 / 5 of the world's population suffers from various types and degrees of central nervous system (CNS) diseases, including brain tumors, acute or chronic pain syndrome, epilepsy, encephalitis, cerebral ischemia and neurodegeneration Diseases (e.g. Alzheimer's, Parkinson's, etc.). As the world's population ages, this trend will intensify and have serious implications for human health. The existence of the blood-brain barrier (BBB) ​​has a certain protective effect on the human central nervous system, but it also restricts many substances from entering the brain from the blood. Almost all macromolecules and 95% of small molecule drugs cannot effec...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K47/54A61K45/00A61P25/28C07H1/00C07H13/04
CPCA61K45/00C07H1/00C07H13/04
Inventor 吴勇海俐管玫郭丽赵毅卢润鑫王林慧
Owner SICHUAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com